Nancy Louise Hill

Nancy Louise Hill is a declared insider of Adaptive Biotechnologies Corp, with filings sourced from SEC (Form 4). Between 1 July 2019 and 19 January 2021, the trades on record add up to 24 filings.

In open-market terms, that means 4 purchases worth €198k on one side and 11 sales worth €9.6M on the other. Taken together, the sales exceed the purchases by €9.4M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 9 option exercises. Since January 2021: no purchases and 1 sale on the market.

Half of the purchases are above €7,973 and half below. On 4 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 4 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -26.1%. These figures describe past trades and do not predict future prices.

Most recently, on 21 January 2021, the filings show an option exercise worth €1,391 in Adaptive Biotechnologies Corp. The most recent open-market purchase was published on 3 July 2019, 2,685 days ago. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.